HCV Eradication with Direct-Acting Antivirals Does Not Impact HCC Progression on the Waiting List or HCC Recurrence after Liver Transplantation

BACKGROUND: The introduction of direct-acting antivirals (DAA) for HCV has led to high rates of HCV eradication. Treatment of patients awaiting liver transplantation (LT) has been controversial. Recent data suggests that DAA treatment may accelerate recurrent HCC. The impact of DAA on delisting for...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Can J Gastroenterol Hepatol
Hauptverfasser: Emamaullee, Juliet A., Bral, Mariusz, Meeberg, Glenda, Montano-Loza, Aldo J., Bain, Vincent G., Burak, Kelly Warren, Bigam, David, Shapiro, A. M. James, Kneteman, Norman
Format: Artigo
Sprache:Inglês
Veröffentlicht: Hindawi 2019
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6354133/
https://ncbi.nlm.nih.gov/pubmed/30775356
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/2509059
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge